Pfizer raising money by selling Zoetis animal products division. Last year raised billions by selling
Nestles nutritional division. Pfizer speaks about wanting to return to its core pharmaceutical business and has expressed interest in biosimilars and orphan drugs to treat niche diseases. Time to spend some of the cash.
Thats strange that an israeli paper is publishing rumors on an irish biotech. what was the paper that reported the story?
Also, its worth noting that the press out today said the israeli paper published that PLX had an offer from PFE as well as was in some kind of talks with citgroup over options and the latter of these has been confirmed, so I personally think we can assume the former is true as well.
Finally, there is a big conference next tuesday, so we should be getting more then at the latest.